GlassScriptPhysician profile
David M Kaufman
NPI 1104914100
$1,099.37
in general payments reported to CMS, 2019-2025
21 companies · $99.36 in 2025
The $99.36 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $106 · 2021: $371 · 2022: $216 · 2023: $30.70 · 2024: $160 · 2025: $99.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $290.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $290.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $218.45 | 2020-2022 | |
| Astellas Pharma US INC | $182.68 | 2021-2023 | Myrbetriq |
| Endo USA, INC. | $125.00 | 2024 | Xiaflex |
| Myovant Sciences INC. | $101.93 | 2022 | |
| Olympus America INC. | $69.64 | 2025 | Itind System |
| Tepha INC | $60.20 | 2019 | |
| Evofem Biosciences, INC. | $48.04 | 2021 | |
| Janssen Biotech, INC. | $29.72 | 2025 | Erleada |
| Urovant Sciences INC | $24.87 | 2021 | |
| Scynexis, INC. | $24.81 | 2022 | |
| Amag Pharmaceuticals, INC. | $24.38 | 2019 | |
| Mayne Pharma Commercial LLC | $24.09 | 2022 | |
| Allergan, INC. | $22.84 | 2020 | |
| Antares Pharma, INC. | $20.75 | 2022 | |
| Verity Pharmaceuticals INC. | $20.20 | 2024 | Trelstar |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19.92 | 2021 | |
| Myriad Genetic Laboratories, INC. | $18.56 | 2021 | |
| Avadel Specialty Pharmaceuticals, LLC | $16.99 | 2019 | |
| Therapeuticsmd, INC. | $16.79 | 2022 | |
| Axonics, INC. | $15.22 | 2024 | Bulkamid |
| Pfizer INC. | $14.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kaufman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.